Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression and Function of Ghrelin and Its Receptor, Growth Hormone Secretagogue Receptor TWEAK Protein and Its Receptor Fn14 in Human Endometrial Cancer

NCT01075386 is registered in ClinicalTrials.gov with Queensland Centre for Gynaecological Cancer as lead sponsor.

NCT NCT01075386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01075386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression and Function of Ghrelin and Its Receptor, Growth Hormone Secretagogue Receptor TWEAK Protein and Its Receptor Fn14 in Human Endometrial Cancer
Lead sponsor
Queensland Centre for Gynaecological Cancer
Phase
Observational
Overall status
Completed
Start date
October 31, 2009
Completion date
December 31, 2018
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer